2015
DOI: 10.2807/1560-7917.es2015.20.8.21045
|View full text |Cite
|
Sign up to set email alerts
|

A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011

Abstract: We present a pilot validation study performed on 10 European Union (EU) Member States, of a point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in Europe in 2011 involving 29 EU/European Economic Area (EEA) countries and Croatia. A total of 20 acute hospitals and 1,950 patient records were included in the pilot study, which consisted of validation and inter-rater reliability (IRR) testing using an in-hospital observation approach. In the validation, a sensitivity of 8… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 15 publications
2
12
0
Order By: Relevance
“…During the SNHPS, we did not have resources needed for the concurrent validation of data collection methods within the European point prevalence survey of healthcare-associated infections and antimicrobial use in Europe in 2011 validation study performed in 10 EU Member States in 20 acute hospitals. The sensitivity of 83% (95% CI: 79%–87%) and specificity of 98% (95% CI: 98%-99%) were found for HAIs ( 6 ). The level of agreement between the primary survey data collection and validation of results were very good for HAIs overall (Cohen’s κappa (κ): 0.81), and across all the types of HAIs (the range: from 0.83 for bloodstream infections to 1.00 for lower respiratory tract infections).…”
Section: Discussionmentioning
confidence: 99%
“…During the SNHPS, we did not have resources needed for the concurrent validation of data collection methods within the European point prevalence survey of healthcare-associated infections and antimicrobial use in Europe in 2011 validation study performed in 10 EU Member States in 20 acute hospitals. The sensitivity of 83% (95% CI: 79%–87%) and specificity of 98% (95% CI: 98%-99%) were found for HAIs ( 6 ). The level of agreement between the primary survey data collection and validation of results were very good for HAIs overall (Cohen’s κappa (κ): 0.81), and across all the types of HAIs (the range: from 0.83 for bloodstream infections to 1.00 for lower respiratory tract infections).…”
Section: Discussionmentioning
confidence: 99%
“…There were striking differences in antimicrobial prescription patterns between Indian and European centers. European centers used narrow spectrum antimicrobials consisting mainly of penicillins, sulphonamides, aminoglycosides and other betalactams, while in the Indian centers high-end reserve antibiotics like piperacillin-tazobactam and carbapenems were commonly used [7][8][9].…”
Section: Discussionmentioning
confidence: 99%
“…The extrapolation of the RMCR results to the 1655 eligible patients (UMCL patients included into the SNHPS without neonates and duplicates) was performed. We used the same approach as described in Reilly et al ( 11 ). The positive predictive value (PPV) and negative predictive value (NPV) were calculated from combined RMCR and SNHPS datasets.…”
Section: Methodsmentioning
confidence: 99%
“…In order to contribute to the accuracy of results of future surveys, sensitivity and specificity of methods used should be determined regularly ( 9 , 10 ). Recently, the results of the ECDC pilot validation of the EUPPS in 10 European Union (EU) Member States conducted in 2011 were published ( 11 ). The overall sensitivity and specificity of the method used for ascertainment of HAIs were estimated to be 83% and 98%, respectively.…”
Section: Introductionmentioning
confidence: 99%